Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LOREEV XR

LORAZEPAM

Standard Dose
1.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LOREEV XR is listed in Drugs@FDA under application 214826 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LORAZEPAM Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 1.5MG Sponsor ALMATICA Submission history Latest submission status date: 2023-01-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOREEV XR is listed in Drugs@FDA under application 214826 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LORAZEPAM Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 1.5MG Sponsor ALMATICA Submission history Latest submission status date: 2023-01-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
LOREEV XR (LORAZEPAM) | Drug Monograph | MedicHelpline